LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 5 of 15: Mean cell count and mean growth rate across biological replicate 2. - Dataset (ID:20241)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | PF431396 | 0.04 | uM | LJP5 | 72 | hr | 1389 | 4828 | 5667 | 0.8519 | 0.8038 |
MCF7 | PF477736 | 0.04 | uM | LJP5 | 72 | hr | 1389 | 3686 | 5667 | 0.6503 | 0.5368 |
MCF7 | PF562271 | 0.04 | uM | LJP6 | 72 | hr | 1389 | 4722 | 5667 | 0.8332 | 0.7790 |
MCF7 | PHA-665752 | 0.04 | uM | LJP5 | 72 | hr | 1389 | 6381 | 5667 | 1.1258 | 1.1667 |
MCF7 | PHA-793887 | 0.04 | uM | LJP6 | 72 | hr | 1389 | 2290 | 5667 | 0.4041 | 0.2106 |
MCF7 | PI103 | 0.04 | uM | LJP6 | 72 | hr | 1389 | 4179 | 5667 | 0.7374 | 0.6522 |
MCF7 | PLX-4720 | 0.04 | uM | LJP5 | 72 | hr | 1389 | 6242 | 5667 | 1.1014 | 1.1343 |
MCF7 | QL-X-138 | 0.04 | uM | LJP6 | 72 | hr | 1389 | 3387 | 5667 | 0.5976 | 0.4670 |
MCF7 | QL-XII-47 | 0.04 | uM | LJP6 | 72 | hr | 1389 | 4059 | 5667 | 0.7163 | 0.6241 |
MCF7 | Radicicol | 0.04 | uM | LJP5 | 72 | hr | 1389 | 3973 | 5667 | 0.7011 | 0.6040 |
MCF7 | Radicicol | 0.04 | uM | LJP6 | 72 | hr | 1389 | 3671 | 5667 | 0.6477 | 0.5333 |
MCF7 | Seliciclib | 0.04 | uM | LJP5 | 72 | hr | 1389 | 5996 | 5667 | 1.0579 | 1.0767 |
MCF7 | Ruxolitinib | 0.04 | uM | LJP5 | 72 | hr | 1389 | 5760 | 5667 | 1.0163 | 1.0216 |
MCF7 | XL147 | 0.04 | uM | LJP5 | 72 | hr | 1389 | 6668 | 5667 | 1.1764 | 1.2337 |
MCF7 | Saracatinib | 0.04 | uM | LJP6 | 72 | hr | 1389 | 4594 | 5667 | 0.8106 | 0.7491 |
MCF7 | Selumetinib | 0.04 | uM | LJP6 | 72 | hr | 1389 | 4868 | 5667 | 0.8590 | 0.8132 |
MCF7 | Sirolimus | 0.04 | uM | LJP6 | 72 | hr | 1389 | 3193 | 5667 | 0.5635 | 0.4218 |
MCF7 | Sorafenib | 0.04 | uM | LJP6 | 72 | hr | 1389 | 5186 | 5667 | 0.9150 | 0.8874 |
MCF7 | SU11274 | 0.04 | uM | LJP5 | 72 | hr | 1389 | 6419 | 5667 | 1.1325 | 1.1755 |
MCF7 | Fedratinib | 0.04 | uM | LJP5 | 72 | hr | 1389 | 6059 | 5667 | 1.0690 | 1.0914 |
MCF7 | TGX221 | 0.04 | uM | LJP5 | 72 | hr | 1389 | 4677 | 5667 | 0.8253 | 0.7685 |
MCF7 | Torin1 | 0.04 | uM | LJP6 | 72 | hr | 1389 | 1882 | 5667 | 0.3321 | 0.1153 |
MCF7 | Torin2 | 0.04 | uM | LJP5 | 72 | hr | 1389 | 1493 | 5667 | 0.2635 | 0.0244 |
MCF7 | Tozasertib | 0.04 | uM | LJP5 | 72 | hr | 1389 | 1560 | 5667 | 0.2752 | 0.0399 |
MCF7 | Trametinib | 0.04 | uM | LJP5 | 72 | hr | 1389 | 2684 | 5667 | 0.4736 | 0.3028 |